Investor News Fresenius Medical Care AG & Co. KGaA Investor Relations Else-Kr ner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: ir@fmc-ag.com North America: Te

Medical Care Reports Preliminary Second

First Six Months 2008 Results

Summary Second Quarter 2008 (preliminary):

Summary First Half 2008 (preliminary):

Bad Homburg, Germany Fresenius Medical Care

AG & Co. KGaA ( the Company ), the world s largest provider

of dialysis products and services, today announced preliminary results for the

second quarter and the first six months of 2008. The disclosure of the

Company`s preliminary results on an accelerated basis has been triggered as a

result of the announcement by Fresenius SE today.

Based on preliminary data, the

total revenue for the second quarter 2008 increased by 11% (7% at constant

currency) to $2,665 million. Operating income rose by 9% to

$428 million. This very good performance was based on an operating margin

of 16.1% compared to 16.3% for the same quarter in 2007. Net income in the

second quarter 2008 was $209 million, an increase of 17%.

First Six Months 2008

$5,177 million, up 10% from the first six months of 2007. Adjusted for

currency, net revenue rose by 6% in this period. Operating income rose by 8% to

$816 million, resulting in an operating margin of 15.8% after 16.0% in the

same period in 2007. In the first six months of 2008, net income was

$395 million, up 17% from the first six months of 2007.

final figures for the first half of 2008 and the outlook for the full year will

be provided on July 30, 2008, as originally scheduled.

Medical Care is the world s largest integrated provider of products and

services for individuals undergoing dialysis because of chronic kidney failure,

a condition that affects more than 1,600,000 individuals worldwide. Through its

network of 2,297 dialysis clinics in North America, Europe, Latin America,

Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to

177,059 patients around the globe. Fresenius Medical Care is also the world s

leading provider of dialysis products such as hemodialysis machines, dialyzers

and related disposable products. Fresenius Medical Care is listed on the

Frankfurt Stock Exchange (FME, FME3) and the New York Stock Exchange (FMS,

FMS/P).For more information about Fresenius Medical Care visit the Company s

website at www.fmc-ag.com.

This release contains forward-looking

statements that are subject to various risks and uncertainties. Actual results

could differ materially from those described in these forward-looking

statements due to certain factors, including changes in business, economic and

competitive conditions, regulatory reforms, foreign exchange rate fluctuations,

uncertainties in litigation or investigative proceedings, and the availability

of financing. These and other risks and uncertainties are detailed in Fresenius

Medical Care AG & Co. KGaA s reports filed with the U.S. Securities and

Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any

responsibility to update the forward-looking statements in this release.